Control Arm Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

Fortvita Biologics (USA)Inc.1
CHU de Quebec-Universite Laval1

Indications

Cancer2
iO Resistant sqNSCLC1
Non-Muscle Invasive Bladder Cancer1
Lung Cancer1

Other1 trial

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

Phase 2

Jonesboro, Arkansas1 trial

IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

St. Bernards Healthcare

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.